United Therapeutics (UTHR) Total Debt Growth (1y) (2010 - 2025)
Powered by 
Analysis
United Therapeutics (UTHR) Total Debt Growth (1y) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.24 Bn | 623.49 Bn | 17.26 Bn | -2.50% |
| 2 | AbbVie | 443.24 Bn | 436.67 Bn | 12.70 Bn | -4.39% |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | 52.27% |
| 4 | Novartis Ag | 266.33 Bn | 258.64 Bn | 11.24 Bn | 15.32% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 2.26% |
| 6 | Sanofi | 52.37 Bn | 44.99 Bn | 10.79 Bn | 8.51% |
| 7 | Revolution Medicines | 44.03 Bn | 44.03 Bn | - | - |
| 8 | Incyte | 25.35 Bn | 20.82 Bn | 1.57 Bn | -17.14% |
| 9 | United Therapeutics | 21.58 Bn | 18.92 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -66.67% |
| Dec 31, 2024 | -57.14% |
| Sep 30, 2024 | -50.00% |
| Jun 30, 2024 | -37.50% |
| Mar 31, 2024 | -25.00% |
| Dec 31, 2023 | -12.50% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -5.88% |
| Sep 30, 2020 | -20.00% |
| Jun 30, 2020 | -23.81% |